Elbit Medical Technologies Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was USD 0.308 million compared to USD 0.065 million a year ago. Net loss was USD 2.53 million compared to USD 4.08 million a year ago.

Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.03.